More About the Author
Almorexant (INN, codenamed ACT-078573) is an orexin antagonist, functioning as a competitive receptor antagonist of the OX1 and OX2 orexin receptors, which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia.
Review and Comments
Rate the Book
Simulink - CDMA Reference Blockset For Use with Simulink User’s Guide Version 1 0 out of 5 stars based on 0 ratings.